期刊文献+

阿司匹林与依那普利合用对兔动脉粥样硬化模型血中PGI_2、TXA_2和NE的影响

EFFECT OF ASPIRIN COMBINED WITH ENALAPRIL ON PROSTACYCLIN, THROMBOXONE A_2 AND NOREPINEPHRINE IN BLOOD OF ARTERIOSCLEROSIS RABBIT MODELS
下载PDF
导出
摘要 目的 :阿司匹林 (ASA)和依那普利 (ENA)单用或合用时 ,检测兔血中前列环素 (PGI2 )、血栓素A2 (TXA2 )和去甲肾上腺素 (NE)的变化 ,探讨两者的相互作用。方法 :6 0只新西兰兔随机分成 5组 ,高脂饲料喂养制备动脉粥样硬化模型 ,于连续投药八周前后分别采血检测PGI2 、TXA2 和NE。结果 :ASA与ENA合用时PGI2 /TXA2 显著上升 (P <0 .0 0 1) ,血清NE浓度明显下降 (P <0 .0 0 1)。结论 :对兔动脉粥样硬化模型 ,ASA和ENA合用时PGI2 /TXA2 比值的上升 ,NE浓度下降 ,有协同作用。 Objective:To explore the interaction of aspirin (ASA)combined with enalapril (ENA) by prostacyclin (PGI 2), thromboxone A 2 (TXA 2) and norepinephrine (NE) in blood of arteriosclerosis rabbit models. Methods:60 New Zealand rabbits were randomly distributed into 5 groups. One group was fed with standard fodder; the others were fed with high lipoid-diet. Before and after 8 weeks' administration consecutively, plasma PGI 2 and TXA 2, serum NE were evaluated.Results:ASA combined with ENA ted to a significant increase in PGI2/TXA2 ( P <0.001) together with a significant decrease in NE levels ( P <0.001) in the rabbits' blood. Conclusions: The results suggest that there is a synergism-action between aspirin and ACE inhibitors due to increased PGI 2/TXA 2 and decreased NE levels.
出处 《中国现代医学杂志》 CAS CSCD 2003年第14期44-46,共3页 China Journal of Modern Medicine
关键词 阿司匹林 依那普利 去甲肾上腺素 前列环素 血栓素A2兔动脉粥样硬化模型 Aspirin Enalapril Prostacyclin Thromboxone A 2 Norepinephrine Arteriosclerosisrabbit Model
  • 相关文献

参考文献8

  • 1李兢,庄汉屏.阿司匹林与依那普利或氯沙坦合用对兔循环中前列环素、血栓素A_2和去甲肾上腺素的影响[J].中国现代医学杂志,2002,12(15):13-16. 被引量:3
  • 2Seydi N, Maruyzraa R, Levi R, et al. Bradykinin activates a cross-signaling pathway between sensory and adrenergic nerve endings in the heart: a novel mechanism of ischemic norephinephrine release?J Pharmacol.Exp Ther,1999; 290 : 656 - 663.
  • 3Lambert GW, Kaye DM, Lefkovits J, et al. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients.Circulation,1995;92(7):1813-1818.
  • 4Takkouche B, Etminan M, Caamano F, et al. interaction between aspirin and ACE Inhibitors; resolving discrepancies using a meta -analysis. Drug Saf,2002; 25(5) : 373-378.
  • 5Fonarow GC, Gawlinski A, Moughrabi S, et al. Improved treatment of coronary heart disease by implementation of a Cardiac Hospi-talization Atherosclerosis Management Program (CHAMP). Am. J Cardiol,2001 ;87(7) : 819-822.
  • 6Wojakowski W,,Gminski J, Siemianowiez K, et al. The influence of angiotensin converting enzyme inhibitors on lipid peroxidation in sera and aorta of rabbits in diet - induced hypercholesterolemia. Int J Mot Med,2000; 6(5): 591-594.
  • 7Davie AP, McMurray JJ. Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor. Br J Clin Pharmacol, 2002; 53(1):37-42.
  • 8Hatta E, Mamyama R, Marshal SJ, et al. Bradykinin promotes ischemic norepinephrine release tn guinea pig and human hearts. J Pharmacol Exp Ther, 1999;288:919-927.

二级参考文献1

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部